Response of tumors to therapy studied by 31P magnetic resonance spectroscopy.
Magnetic resonance (MR) methods have been used to study the metabolic and vascular response of model tumors to tumor necrosis factor (TNF). Magnetic resonance measurements demonstrated acute reductions in tumor blood flow, measured from tumor uptake of D2O, and in tumor adenosine triphosphate (ATP), measured by 31P magnetic resonance spectroscopy (MRS) following administration of TNF. The decrease in ATP generally followed reduction in tumor blood flow, and therefore was probably due to ischemia caused by damage to tumor vasculature. Superficial human tumors have been studied by MRS to characterize their 31P spectra, and to measure metabolic changes during therapy. The ratio of the intensities of the phosphomonoester (PME) and ATP resonances (PME/ATP) was much higher in tumors than in the normal tissue displaced by the tumors. During therapy, decreases in PME/ATP were detected that paralleled, but did not anticipate, decreases in tumor size. In some cases, a transient increase in PME/ATP was detected during therapy, which did not correlate with changes in tumor size, and which may reflect stimulation of cell growth in some tumor zones.
Karczmar
G S
GS
Magnetic Resonance Unit, Veterans Administration Hospital, San Francisco, CA 94121.
Meyerhoff
D J
DJ
Speder
A
A
Valone
F
F
Wilkinson
M
M
Shine
N
N
Boska
M D
MD
Weiner
M W
MW
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D010758:Phosphorus; D051381:Rats; D012513:Sarcoma, Experimental / Q000098:blood supply / Q000188:drug therapy / Q000378:metabolism; D013403:Sugar Phosphates / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D013403:Sugar Phosphates; D014409:Tumor Necrosis Factor-alpha; D010758:Phosphorus; D000255:Adenosine Triphosphate